In an unusual business, biotechnology Modern (NASDAQ: MRNA) and equestrian king Uber Technologies (NYSE: UBER) is working on a program to raise awareness of coronavirus vaccines.
According to a press release published jointly by both companies, they will ‘initially’ work together to provide accessible, credible information on vaccine safety through Uber’s in-app messages … [and] is working with public health and other organizations to identify additional opportunities to support ongoing efforts to broaden access to COVID-19 vaccines. ‘
Image Source: Getty Images.
Moderna has developed and marketed one of only two coronavirus vaccines that has received US Food and Drug Administration (FDA) emergency use authorization. Sy mRNA-1273, and Pfizer and BioNTechBNT162b2 is currently distributed and administered throughout the country. Both rollouts are slow. Even if only slightly effective, this new initiative would be welcome.
In addition to raising awareness of coronavirus vaccines, Moderna and Uber are considering more direct ways to get Americans vaccinated. This includes the inclusion of Uber ride schedules in discussions for immunization appointments, among others.
In the press release, Stephane Bancel, CEO of Moderna, said that this is only the first of a series of collaborations for the biotechnology.
“As part of our commitment to address COVID-19, Moderna will work with a coalition of partners to educate, build trust and raise awareness of vaccination in the pandemic-affected communities. , “said Bancel. He did not identify those partners.
Last month, Uber promised to offer 10 million free or discount rides for people to receive their vaccines. This initiative aims to serve people in underprivileged communities.